Abstract Uricase is an important medical enzyme which can be used to determine urate in clinical analysis, to therapy gout, hyperuricemia, and tumor lysis syndrome. Uricase of Candida utilis was successfully expressed in Hansenula polymorpha under the control of methanol oxidase promoter using Saccharomyces cerevisiae α-factor signal peptide as the secretory sequence. Recombinant H. polymorpha MU200 with the highest extracellular uricase production was characterized with three copies of expression cassette and selected for process optimization for the production of recombinant enzyme. Among the parameters investigated in shaking flask cultures, the pH value of medium and inoculum size had great influence on the recombinant uricase production. The maximum extracellular uricase yield of 2.6 U/ml was obtained in shaking flask culture. The yield of recombinant uricase was significantly improved by the combined use of a high cell-density cultivation technique and a pH control strategy of switching culture pH from 5.5 to 6.5 in the induction phase. After induction for 58 h, the production of recombinant uricase reached 52.3 U/ml (about 2.1 g/l of protein) extracellularly and 60.3 U/ml (about 2.4 g/l) intracellularly in fed-batch fermentation, which are much higher than those expressed in other expression systems. To our knowledge, this is the first report about the heterologous expression of uricase in H. polymorpha.
Introduction
Urate oxidase (uricase, E.C.1.7.3.3), an enzyme found in liver peroxisomes of most mammalian species, catalyzes the oxidation of uric acid to a more soluble and easily excreted compound, allantoin (Nelson and Cox 2004) . Higher primates (apes and humans) lack functional uricase and excrete uric acid as the end product of purine degradation, which is a causative factor of gout (Oda et al. 2002) . Allopurinol is generally used to treat gout. However, in the case of gout associated with renal complications, direct injection of uricase allows a much more rapid resorption of urate nephrolithiases (Vogt 2005) . Uricase has advantages for gout treatment compared with allopurinol. Uricase is also useful for enzymatic determination of urate in clinical analysis by coupling with 4-aminoantipyrine peroxidase system (Klose et al. 1978) . Hyperuricemia and tumor lysis syndrome are serious complications that can occur during chemotherapy for hematologic malignancies. Rasburicase, as a safe and effective alternative to allopurinol for lowering uric acid levels, is made up of a single polypeptide chain with 301 amino acids and is produced from Saccharomyces cerevisiae harboring Aspergillus flavous uricase gene. Rasburicase has been used for the management of anticancer-therapy-induced hyperuricemia in pediatric patients in the EU and USA and in adult patients in the EU (Oldfield and Perry 2006) . Thus, uricase is an important medical enzyme. Cross-reaction studies with preparation of the enzyme from three microbial species, Candida utilis, A. flavous, Bacillus fastidiosus, indicated that the microbial enzyme exhibits a high degree of antigenic independence (Fitzpatrick and McGeeney 1975) . Therefore, the uricase from Hansenula polymorpha harboring C. utilis uricase gene may be an alternative for the Rasburicase with the concern that repeated administration of the enzyme has resulted in antibody production, which reduces the efficacy of the treatment.
Uricase has been found in mammalian (Wu et al. 1989 ), plant (Suzuki and Verma 1991) , and microbial cells (Yazdi et al. 2006; Lotfy 2008) . Microorganisms, such as bacteria, yeast, and filamentous fungi, are important sources of uricase. Genes encoding uricase have been cloned from A. flavus, A. nidulans, C. utilis, Arthrobacter globiformis, Cellulomonas flavigena and symbiont of Nilaparvata lugens (Suzuki et al. 2004) , and expressed in Escherichia coli (Li et al. 2006) . Uricase from A. flavus was expressed in the yeast S. cerevisiae in a soluble and active form (Leplatois et al. 1992) . However, the recombinant uricase from E. coli or S. cerevisiae still has the problem with low productivity and cost-effective separation for medical applications (Li et al. 2006) . As the methylotrophic yeast, H. polymorpha in particular has been studied extensively for its highly regulated biogenesis of peroxisomes, nitrate assimilation, and methanol metabolism. The expression of the key methanolmetabolizing enzymes, such as methanol oxidase (MOX; Ledeboer et al. 1985) and formate dehydrogenase (Gellissen et al. 1996) , can amount up to one third of the total cellular protein during growth on methanol. The existence of inducible strong promoters, the formation of integrants in high copy numbers, high cell density (>100 g dry weight per liter) in cheap defined media, and the low antigenicity of proteins produced in H. polymorpha make H. polymorpha a highly competitive system for the production of recombinant proteins for medical application (Gellissen 2000; Gellissen et al. 2005) . Several eukaryotic proteins with clinical and therapeutic values, such as hirudin, hepatitis B surface B antigen, aprotinin, and human urokinase, have been expressed in H. polymorpha (Gellissen 2000) . To date, there is no report about expression of uricase in the methylotrophic yeast H. polymorpha.
The uricase gene (UOXu) of C. utilis has been cloned. The gene contains 909 base pairs without any intron and encodes a protein composed of 303 amino acid residues with a mass of 34,1463 Da (Koyama et al. 1996) . The C. utilis uricase does not require any cofactor for the enzymatic oxidation (Bonnete et al. 2001) . The codons used in the two species of yeast C. utilis and H. polymorpha are quite similar (http://www.kazusa.or.jp/codon/). In this study, the UOXu gene from C. utilis was expressed in H. polymorpha for the first time, and process of cell growth and product formation was optimized.
Materials and methods

Microorganisms and cultivation media
C. utilis CGMCC 2.120 was used as the source of uricase gene (UOXu). H. polymorpha CGMCC 2.2498 was used as the host for heterologous protein expression. E. coli TOP10 (Invitrogen, USA) was used for maintenance and propagation of plasmid. E. coli cells were cultivated at 37°C in low salt LB medium (1% tryptone, 0.5% yeast extract, and 0.5% NaCl, pH 7.5) supplemented with 25 μg/ml of zeocin when necessary. Yeast cells were grown at 37°C in YPD medium (Adams et al. 1997) . For uricase production, YPG medium (2% peptone, 1% yeast extract, 1% glycerol), YPM medium (2% peptone, 1% yeast extract, 1% methanol), synthetic minimal (SD) medium SDG (0.7% yeast nitrogen base, 1% glycerol), and SDM medium (0.7% yeast nitrogen base, 1% methanol) were used.
DNA manipulations
Standard DNA manipulations in E. coli were performed as described by Sambrook and Russell (2001) . The isolation of yeast chromosomal DNA was carried out with the methods described by Adams et al. (1997) .
Construction of recombinant expression plasmid
The S. cerevisiae α-factor signal sequence (α-MF) was polymerase chain reaction (PCR)-amplified from plasmid pGAPZα-A (Invitrogen, USA) using primers α-L (5′-CAC AAGCTTCGAAACGATGAGATTTCCTTC-3′, HindIII) and α-R (5′-CGTGAATTCAGCTTCAGCCTC-3′, EcoRI). Methanol oxidase gene MOX promoter (MOXp) was amplified from plasmid pHIPX4 (Gietl et al. 1994 ) using primers MOXp-L (5′-TCAAGATCTTCGACGCGGAGAACGA TCT-3′, BglII) and MOXp-R (5′-CCGAAGCTTTGTTTT TGTACTTTAGATTGATG-3′, HindIII). The BglII-EcoRI digested plasmid pGAPZα-A was ligated with the BglIIHindIII digested MOXp and HindIII-EcoRI digested α-MF. The resulting plasmid was designated as pMOXZα-A.
Uricase gene UOXu was amplified from the genome DNA of C. utilis using the primers UOXu-L (5′-CTGGAATTC ATGTCAACAACGCTCTCATC-3′, EcoRI) and UOXu-R (5′-GCCTCTAGATTACAACTTGGTCTTCTCCT-3′, XbaI). After digested by EcoRI and XbaI, the 0.9 kb PCR product (UOXu) containing uricase coding sequence was inserted into EcoRI and XbaI sites in plasmid pMOXZα-A to generate the recombinant expression plasmid pMOXZα-UOXu (Fig. 1) .
Transformation of H. polymorpha
Plamids pMOXZα-UOXu and pMOXZα-A were linearized respectively with SacII and ScaI. H. polymorpha CGMCC 2.2498 cells were transformed by electroporation with 10 μg of linearized plasmid DNA using a Bio-Rad GenePulser Apparatus (1.5 kV, 50 μF, 200 Ω, 3 ms). The transformed yeast cells were firstly grown in YPD medium containing 1 mM Tris-HCl and 1 mM MgCl 2 for 2 h and then spread on YPD plate containing 100 μg/ml of zeocin and cultured at 37°C for 3 days. The high-copy integrated transformants were screened on YPD plates containing different concentrations (100, 200, 500 μg/ml) of zeocin. The transformants containing the desired expression cassette were confirmed by PCR analysis using genomic DNA as template (Linder et al. 1996) .
Determination of gene copy number
Transformants were taken at random from each plate containing different concentration of zeocin and used for detection of integration copies by Southern blot analysis. A 0.9-kb fragment of the MOXp gene was digoxin-labeled using the DIG DNA labeling kit (Roche Diagnostics). In Southern blot experiments, 12 μg of genomic DNA was digested with BglI. Fragments were separated by agarose gel electrophoresis and transferred onto nitrocellulose membranes. Hybridization, washing and chemiluminescent detection were carried out according to protocols given by Roche Diagnostics. Chromosomal DNA digested with BglI was hybridized to the MOXp probe. Densitometry analysis of the film was used to estimate the copy number of the integrated plasmid. The H. polymorpha CGMCC 2.2498 MOXp was used as single copy control.
Engineered strain stability analysis Recombinant strains were firstly transferred onto YPD slant for ten generations. Each generation was cultivated for 36 h at 37°C. Then, plate streaking of the tenth generation culture was performed. After 2 days' cultivation at 37°C, ten single colonies were chosen randomly and incubated in YPD medium. The copy number of the chosen clone was analyzed by Southern blot.
Shake-flask cultures
Yeast cells were initially grown in 5 ml YPG medium at 37°C in a shaking incubator (200 rpm) for 18 h. Cells were then inoculated to 30 ml YPM medium in 250 ml shake flasks and cultured at 37°C. The uricase expression was induced by adding methanol to a final concentration of 1.0% every 12 h. Samples were taken periodically to determine the cell biomass and recombinant uricase production.
Recombinant uricase production in bioreactor cultures
Fermentation was performed in a 5-l computer-controlled bioreactor (Shanghai Baoxing Bioengineering Equipment, Shanghai, China). The primary culture was prepared by inoculating a single colony of recombinant H. polymorpha to 20 ml of YPG medium and growing at 37°C for 20 h. The secondary inoculum was prepared by transferring 20 ml of primary culture to 200 ml of YPG medium in a 500-ml flask. After 20 h cultivation at 37°C and 200 rpm, an OD 600 of 10-12 was obtained, and 400 ml of this culture was inoculated into the bioreactor containing 2.0 l of fermentation medium. During fermentation, the temperature was set at 37°C. Airflow rate was controlled at 6 l/min. The dissolved oxygen was maintained at 20% saturation using a D.O.-agitation cascade system, and pure oxygen was supplied as needed. The dissolved oxygen was measured with an autoclavable O 2 sensor. Samples were withdrawn periodically to determine OD 600 , biomass, methanol concentration, and uricase production.
For batch fermentation, all cultures were initially grown in YPG medium with 20 g/l of glycerol as carbon source. After the consumption of glycerol (about 14 h), one dose of 3.0 g/l methanol was added for making cells adapt to methanol. After the adaptation period, methanol was fed into medium at appropriate feeding rate to maintain the methanol concentration in the fermentation broth at around 0.65% Mayson et al. 2003) . Culture pH controlled with 28% ammonium hydroxide, and 1 N phosphoric acid was maintained at 5.0, 5.5, 6.0, 6.5, or 7.0 to investigate the effect of pH on cell growth and uricase production. A pH control strategy of switching culture pH in the induction Fig. 1 Physical maps of recombinant plasmid pMOXZα-UOXu phase from 5.5 to 6.5 of two-phase fed-batch culture was investigated.
For high cell density fermentation, glycerol fed-batch cultivation and pH-controlled strategy were used. The fermentation can be divided into various phases, namely, the glycerol batch phase, glycerol fed-batch phase, and a brief transition phase followed by the methanol fed-batch induction phase (Sinha et al. 2003) . The initial cultivation in YPG medium containing 4 % glycerol continued until the glycerol was consumed up (about 24 h) and was followed by glycerol-fed phase for 3 h at a continuous feeding rate of 20 g l −1 h −1 of glycerol. At the end of glycerol fed-batch phase, methanol feeding was started at rate of 1 ml l −1 h −1 to make cells adapt to methanol. After 3 h of transition phase, methanol feeding rate was increased to maintain the methanol concentration in fermentation broth at about 0.65% during the whole induction period. The pH was firstly maintained at 5.5 during growth period (glycerol batch and fed-batch phase) then increased up to 6.5 and maintained that value during the whole induction period.
Assay of uricase activity
Uricase activity was assayed using the method described by Klose et al. (1978) . Standard reaction mixture contained 2.2 ml of 2 mM uric acid dissolved in 0.1 M sodium borate buffer (pH 8.5), 0.15 ml of 20 U/ml peroxidase from horseradish, 0.15 ml of 60 mM 4-aminoantipyrine, 0.15 ml of 1.5% phenol, 0.15 ml of 0.1 M sodium borate buffer (pH 8.5), and 0.2 ml of properly diluted enzyme solution in a final volume of 3.0 ml. The mixture was incubated at 25°C for 20 min, and the increase in absorbance at 505 nm was spectrophotometrically measured. One unit of enzyme was defined as the amount of enzyme that produces 1.0 μmol of H 2 O 2 per minute under the standard assay conditions. This method was also confirmed by the method described by Li et al. (2006) by following the disappearance of uric acid detected by a decrease in absorbance at 292 nm. For determination of uricase in yeast cells, samples of the culture were withdrawn, and the cells were collected by centrifugation at 3,000×g (4°C) for 5 min. Yeast cells were washed with distilled water twice and resuspended in 0.1 M borate buffer (pH 8.5) to concentration of 0.6 g/ml and treated by an ultrasonic device. The cell free extract was centrifuged at 11,000×g for 10 min, and the clear supernatant was used for analysis of enzyme activity.
Cell biomass and methanol measurement
Cell concentration was monitored by measuring the optical cell density (OD 600 ) of the culture sample at 600 nm. For determination of cell weight, 1.0 ml of culture sample was centrifuged in tared Eppendorf tubes for 5 min at 3,000×g. Cells were washed twice with distilled water, and the wet cell weight was weighed. Wet cells were dried at 80°C until constant weight was obtained. Biomass was defined as the dry cell weight (DCW) per liter culture (g DCW l −1 ).
Residual methanol was analyzed by gas chromatography according to the method described by Inan and Meagher (2001) .
Degradation kinetics of secreted uricase Degradation kinetics of secreted uricase was determined by incubation of cell-free culture broth at 37°C. Ten milliliters of culture broth was sampled from the fermentation culture and centrifuged for 5 min at 3,000×g. The samples were filtered using 0.2-mm syringe filter. Filtered broth was incubated in cap tubes in the shaking incubator at 37°C. During incubation, 100 μl of culture broth was sampled for uricase assay.
SDS-PAGE analysis
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed as described by Sambrook and Russell (2001) with 12% (w/v) polyacrylamide gels. Equal amounts of samples were loaded on SDS-polyacrylamide gel. Proteins were visualized by staining with Coomassie Brilliant Blue R-250.
Results
Screening of recombinant H. polymorpha clones
The UOXu gene encoding uricase of C. utilis was fused in frame with the alpha factor signal sequence under the control of the MOX promoter in pMOXZα-A to generate the expression plasmid pMOXZα-UOXu (Fig. 1) . Empty vector pMOXZα-A and recombinant plasmid pMOXZα-UOXu were linearized with ScaI and SacII, respectively, and transformed into H. polymorpha CGMCC 2.2498. Transformants were screened for their resistance to zeocin. The colonies resistant to different concentrations of zeocin (100, 200, 500 μg/ml) were checked for the secretory expression of uricase by growing them in YPM medium supplemented with methanol to a final concentration of 1.0% every 12 h. Among the 60 clones tested, clone 200-1 performed the best, with 0.6 U/ml extracellular uricase activity in the supernatant after 60 h of cultivation for a similar biomass production with others (Table 1 ). The number of copies of expression cassette integrated in the genome was estimated for each clone by Southern blot hybridization (Fig. 2) . Table 1 shows a positive correlation between the copy number and zeocin resistance. It is, however, to be noted that this is not always the case and that this should not be taken as a general criterion for strain selection (Laborde et al. 2004 ). The best performing clone (no. 200-1) is characterized with three copies of expression cassette and the resistance to 200 μg/ml of zeocin (Fig. 2) . The clone 200-1 was named as H. polymorpha MU200 and selected for further studies.
Stability of recombinant H. polymorpha strain
The desired expression cassette can be PCR-amplified from all of the ten single colonies of the tenth generation of recombinant strain H. polymorpha MU200. All of the ten single colonies of the tenth generation of recombinant strain harbor the same gene copy number as the origin strain by Southern blot analysis, indicating that the multiple integrants H. polymorpha MU200 was mitotic stable.
Recombinant uricase production in shake flask cultures
Effect of buffer solution and initial pH on recombinant uricase production
To investigate the effects of different buffer solutions on cell growth and uricase production, yeast cells were grown in YPM medium buffered at pH 5.8 with different buffers (0.05 M). The cell growth and extracellular uricase production of recombinant H. polymorpha MU200 were influenced largely by the types of buffer (citric acidphosphate, acetate buffer, dibasic sodium phosphate-sodium acid phosphate, bibasic sodium phosphate-potassium dihydrogen phosphate, potassium dihydrogen phosphate-sodium hydroxide). The maximum uricase production of 0.7 U/ml was obtained in the YPM medium buffered with the potassium dihydrogen phosphate-sodium hydroxide buffer after 60 h of cultivation. YPM media buffered at pH values ranging from 5.8 to 8.0 with potassium dihydrogen phosphate-sodium hydroxide buffer were used to examine the pH dependency of cell growth and uricase production of recombinant H. polymorpha MU200. As shown in Fig. 3a , the optimal initial pH for cell growth was 6.4 with a biomass of 22.7 g DCW l −1 after 60 h of growth at 37°C. However, the maximum extracellular uricase of 1.5 U/ml was obtained at pH 7.0. The specific product yield at pH 7.0 was 2.5-fold of that in nature YPM medium.
Media optimization
Cells were grown in 30 ml of SDG, SDM, YPG, YPM media and the corresponding media containing 1% casamino acids (SDGC, SDMC, YPGC, YPMC) buffered with potassium dihydrogen phosphate-sodium hydroxide buffer (pH 7.0) at 37°C. The buffered YPG medium gave the maximum cell biomass of 29.4 g DCW l −1 , while the maximum extracellular uricase production of 1.5 U/ml was obtained in buffered YPM medium after cultivation of 60 h. The specific product yield in buffered YPM medium was 13-fold of that in buffered YPG medium. Meanwhile, cell growth and uricase production in synthetic minimal media were much lower than those in complex media. Supplementation of 1% casamino acids in synthetic minimal media caused a little increase in both the cell growth and uricase production. Both biomass and product concentration decreased proportionally by 7.1% in YPM media supplemented with casamino acids when compared with YPM medium. The copy number of expression cassette was estimated by Southern blot hybridization. 
Effect of inoculum volume on uricase production
Different amount of wet cell was inoculated to buffered YPM medium to examine the effect of inoculum volume on cell growth and uricase production. As shown in Fig. 3b , after 60 h of cultivation, the biomass increased with the inoculum size, but the maximum extracellular uricase of 2.3 U/ml was obtained at the inoculum volume of 6.0 g wet cell weight per liter.
Time course of recombinant uricase production in shake flask culture
The production of recombinant uricase by H. polymorpha MU200 was investigated in shake flask culture under the optimized conditions. The extracellular production of uricase increased rapidly from 30 to 60 h with a maximum specific growth rate of 0.28 h −1 and reached top at 72 h (Fig. 4) . Finally, a biomass of 18 g DCW l −1 with 2.6 U/ml of extracellular uricase was obtained, which corresponded to 92% of the total expressed uricase. Repeated shake flask experiments were done using methanol as sole carbon source. At the end of each cultivation cycle, 20 ml of cell suspension was left in the shake flask, and 60 ml fresh sterile medium without carbon source was added. Methanol was supplemented to a final concentration of 1.0% every 12 h. During the five cycles, comparable growth and production patterns were obtained. The recombinant strain H. polymorpha MU200 is apparently completely stable.
Recombinant uricase production in bioreactor cultures
Effect of pH on recombinant uricase production Firstly, fermentation was conducted in bioreactor containing 2 l of YPM medium buffered at pH 7.0 with potassium dihydrogen phosphate-sodium hydroxide buffer. A fairly sharp increase in uricase activity was observed in fermentation broth during the first 24 h, and then a sharp decline of uricase activity and biomass occurred. The maximum uricase activity in fermentation broth was only 1.0 U/ml. The increase of pH from 7.0 to 8.5 was observed during the cultivation, which might cause cell lysis and the decline of uricase production. To resolve this problem, the effect of pH on cell growth and uricase expression was investigated in bioreactor cultures. Batch fermentation was conducted at pH values of 5.0, 5.5, 6.0, 6.5 and 7.0, respectively. From the growth profile, it was observed that cell growth was influenced negatively by the high pH, and the maximum biomass was obtained at pH 5.5 (data not shown). For recombinant uricase production, the optimal pH was 6.5 (Fig. 5a,b) . At pH 5.5, the extracellular uricase production reached top of 7.5 U/ml at 58 h, and then enzyme activity was lost very rapidly. When fermentation was performed at pH 6.5 for 62 h, 14.5 U/ml of extracellular uricase and 23.3 U/ml of intracellular uricase were produced. The total specific uricase production at pH 6.5 was 1.7 times of that at pH 5.5. Meanwhile, increase of pH value enhanced the secretion efficiency of recombinant uricase.
The pH-dependent degradation kinetics of secreted uricase in cell-free culture broth was detected. As shown in Fig. 6 , uricase activity in 50 h culture broth with pH values of 5.5 and 6.0 decreased more rapidly than that in cultures with pH values of 6.5 and 7.0. In the case of the pH 5.5, about 78% of initial uricase activity was lost within 25 h. Under the same conditions, more than 85% of initial uricase activity remained in culture broth of pH 6.5 and 7.0. Uricase activity in 66 h culture broth with pH 7.0 degraded much more rapidly than that in samples from 50 h culture, while for pH 6.5, the uricase was still stable. The loss of uricase activity might be caused by the degradation in acidic environment by proteases secreted by the host cells or released from host cell lyses. On the other hand, low pH may cause instability of uricase (Liu et al. 1994) .
Because the best specific growth rate was obtained at pH 5.5 and highest cell-specific uricase production was achieved at pH 6.5, a pH control strategy of switching pH value from 5.5 in cell growth phase to 6.5 in the induction phase was used to improve uricase production. After 14 h cultivation, methanol induction phase started, and the pH value was changed to 6.5 from 5.5. The cell growth was quite similar to that at pH 5.5, but both the intracellular and extracellular uricase production were increased significantly. When compared with the culture at pH 6.5, the intracellular uricase production in pH-shift culture was almost the same, but cell growth and extracellular uricase production increased. The specific yield of extracellular uricase in pH-shift culture was 2.4-and 1.2-fold of those in cultures at pH 5.5 and 6.5 (Fig. 7) .
Recombinant uricase production in high cell density fermentation
To increase the uricase production, high cell density fermentation was conducted as described in "Materials and methods". The initial amount of 4% (v/v) of glycerol was consumed up within 24 h; the biomass reached 40.6 g DCW l −1 . The biomass increased linearly up to 49.5 g DCW l −1 at the end of the glycerol fed-batch phase and 125 g DCW l −1 at the end of the fermentation (Fig. 8) . The maximum specific growth rate in glycerol fed-batch phase was 0.18 h −1 . The induction phase lasted for 68 h. The extracellular uricase activity increased significantly during the first 40 h. The highest extracellular uricase level of 52.3 U/ml was obtained after 58 h of induction, as well as the intracellular activity of 60.3 U/ml. After 86 h of fermentation and 58 h of induction, a total uricase activity of 112,600 U/l was obtained. The extracellular and intracellular yields of uricase in high cell density fermentation increased by 3.7-and 3.5-fold, respectively, compared with the batch fermentation.
The SDS-PAGE analysis of the culture supernatant and cell-free extract showed an apparent molecular mass of 34 kDa of the recombinant uricase (Fig. 9) . The recombinant uricase in culture supernatant was estimated to be 2.1 and 2.4 g/l in the cell-free extract by densitometry analysis of the SDS-polyacrylamide gel. The amino acid sequence of C. utilis uricase has been analyzed by ExPASy Proteomics Server (http://expasy.org/), indicating that there is no glycosylation site. No glycosylated band of uricase was detected by SDS-PAGE analysis (Fig. 9, lanes 6 and 8) .
Discussion
Uricase is an important enzyme for medical application. Uricase from C. utilis, A. flavus, Bacillus. sp, and recombinant uricase from E. coli or S. cerevisiae are now commercially available, but the production procedures still have the problems with low productivity, complicated isolation, and purification procedure for clinical applications (Li et al. 2006; Lotfy 2008) . The methylotrophic yeast H. polymorpha has been proven to be an effective expression system for the production of heterologous proteins with medical application (Gellissen 2000; Gellissen et al. 2005) . In this study, the C. utilis uricase was successfully expressed in H. polymorpha for the first time. The combined use of fed-batch culture and pH-controlled strategy increased the expression level of uricase significantly. The extracellular uricase production of 52.3 U/ml (approximately 2.1 g/l of protein) was obtained, which is much higher than that produced by recombinant E. coli strains (about 6.1 U/ml or 238 mg/l; Koyama et al. 1996; Li et al. 2006) .
Cell growth, specific expression rate, secretion efficiency, and proteolytic degradation of genetically engineered yeast strains are highly dependent on the culture pH (Moon et al. 2002) . Secreted recombinant proteins are often susceptible to proteolytic degradation by various proteases secreted into the medium by the host strain or released from cell lyses. A few methods to deal with this problem have been tried, such as the change of physical environments like culture pH or temperature, nutrient supplementation to inhibit host proteases, site-directed mutagenesis to remove the sequences of identified proteases, and a new reactor design (MacauleyPatrick et al. 2005) . Cultivation techniques can influence proteolysis of recombinant proteins. H. polymorpha is capable of growing across a relatively broad pH range (3.0-7.0). Different pH values were found to be optimal from the point of view of a recombinant protein's stability: pH 6.0 was optimal in the production of recombinant human epidermal factor (Moon et al. 2002) and human serum albumin (Kang et al. 2001) , and pH 2.8 was optimal in the production of IFNα-2a (Muller et al. 2002) . The rational reasons for that are either an improved productivity or stability of the product (Shi et al. 2003) or decreased proteolysis (Jahic et al. 2003) . The pH can be controlled at a favorable value for growth in the growth phase and switched to minimize proteolysis in the induction phase while conducted in a bioreactor (Moon et al. 2002) . The production level of uricase in pH 6.5 was much higher than that in pH 5.5. Obvious degradation of uricase in culture at pH 5.5 was observed, while in pH 6.5, it was degraded slightly. The production level was increased significantly using pH-shift strategy other than by keeping pH at 5.5, 6.0 or 6.5.
A total of 112,600 U/l of uricase was produced by recombinant H. polymorpha MU200. However, only 46.4% of the expressed uricase was excreted to the medium, which might result from the low secretion efficiency of the S. cerevisiae alpha factor signal sequence or uricase itself. The sequence of C. utilis uricase gene has been analyzed by the TMHMM Server v. 2.0 (http://www.cbs.dtu.dk/services/ TMHMM/); there were no predicated transmembrane helices. Trial and error experiments are often required to find the optimum secretion signal for a specific protein (Cereghino et al. 2002) . Therefore, new signal sequences are required to be investigated to enhance the secretion efficiency of uricase. On the other hand, co-expression of chaperon proteins, such as BiP (van der Heide et al. 2002) or calnexin (Klabunde et al. 2007) , may positively affect the secretion of uricase in H. polymorpha.
The results presented here exhibit the ability to generate multi-gram quantities of uricase from H. polymorpha, which may be used for the development of pharmaceutics for the treatment of gout and hyperuricemia.
